The objective of this audit was to assess the effectiveness of controls being implemented and/or developed by the National Disability Insurance Agency (NDIA) to ensure National Disability Insurance Scheme (NDIS) access decisions are consistent with legislative and other requirements.
Autism Aspergers Advocacy Australia (A4) sent a submission to the Joint Standing Committee on the National Disability Insurance Scheme (NDIS) for its Inquiry into Provision of services under the NDIS Early Childhood Early Intervention Approach.
Below is a link to a response on behalf of The Hon Christian Porter MP, Minister for Social Security, to A4's concerns about the lack of autistic representation on the NDIA's Independent Advisory Council (IAC).
The Hon Christian Porter MP
Minister for Social Services
Parliament House
CANBERRA ACT 2600
cc: The Hon Jane Prentice MP, Assistant Minister for Social Services and Disability Services; Mr Alastair McEwin, Disability Discrimination Commissioner; Mr David Bowen, NDIA CEO; Dr Helen Nugent AO, Chair of the NDIA Board.
A Select Committee of the South Australian parliament produced this report.
This report has a lot to say about autistic students (students with autism, students with ASD, students on the autism spectrum). It includes a lot of recommendations. A couple of the recommendations are specific to how autistic students are educated.
A month ago, a NDIS planner in the ACT told a mother that the NDIA had "two publically available reports that the NDIS is using to avoid funding ABA therapies in kids aged 5 and above i.e. school-aged kids". The NDIS planner told the mother:
once kids reach school, the schools are meant to fund appropriate behavioural management plans (also occupational and speech therapy),
as kids after school are too tired to have therapy, then these unnamed studies state that ABA therapy is no longer effective, and
One thing that is important to know about autism up front: There is no cure for autism. So, products or treatments claiming to “cure” autism do not work as claimed. The same is true of many products claiming to “treat” autism or autism-related symptoms. Some may carry significant health risks.
The Food and Drug Administration (FDA) plays an important role in warning these companies against making improper claims about their products’ intended use as a treatment or cure for autism or autism-related symptoms.